MARC details
| 000 -LEADER |
|---|
| fixed length control field |
19818nam a22002177a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
CUTN |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210913163112.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210707b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789389211436 |
| 041 ## - LANGUAGE CODE |
|---|
| Language |
English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.01 |
| Item number |
ANA |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ananthanarayan, R.; Paniker, CK Jayaram. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Ananthanarayan and Paniker's Textbook of Microbiology |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
11th ed., Reba Kanungo |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Telangana |
| Name of publisher, distributor, etc |
Universities Press |
| Date of publication, distribution, etc |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
680p. |
| Dimensions |
216 x 280 mm |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Contents |
Part I General Microbiology<br/><br/>1. Introduction to Microbiology 1<br/><br/>Historical perspective and notable milestones in microbiology 1<br/><br/>Classification, nomenclature and taxonomy 3<br/><br/>2. Morphology and Physiology of Bacteria 7<br/><br/>Microscopy 7<br/><br/>Morphology of bacteria 10<br/><br/>Bacterial cell structure 10<br/><br/>–– Staining techniques 10<br/><br/>Shape of bacteria 13<br/><br/>Arrangement of bacteria 13<br/><br/>Bacterial anatomy 13<br/><br/>Cell envelope 14<br/><br/>Cell interior 16<br/><br/>Additional structures 17<br/><br/>Physiology of bacteria 20<br/><br/>Growth and multiplication of bacteria 20<br/><br/>Bacterial nutrition 22<br/><br/>Bacteriocins 23<br/><br/>3. Sterilisation and Disinfection 26<br/><br/>Sterilising agents 26<br/><br/>Physical agents 26<br/><br/>Chemical agents 31<br/><br/>Sterilisation and disinfection in a health care setting 35<br/><br/>–– Spaulding’s classification 35<br/><br/>–– New methods of sterilisation of<br/><br/>heat-sensitive articles 36<br/><br/>4. Culture and Identification of Bacteria 38<br/><br/>Culture media 38<br/><br/>Culture methods 41<br/><br/>Identification of bacteria 46<br/><br/>5. Genetics of Bacteria 53<br/><br/>Basic principles of molecular biology 53<br/><br/>–– Structure of DNA 53<br/><br/>–– Structure of RNA 54<br/><br/>Mutation 55<br/><br/>Gene transfer 56<br/><br/>Genetic mechanisms of drug resistance in bacteria 60<br/><br/>6. Molecular Techniques Applied to Microbiology 63<br/><br/>Molecular methods applied to disease detection and diagnosis 63<br/><br/>Application of genetic engineering in microbiology 66<br/><br/>Part II Immunology<br/><br/>7. Introduction to Infection and Immunity 68<br/><br/>Infection 68<br/><br/>Sources of infection 69<br/><br/>Methods of transmission of infection 70<br/><br/>Factors predisposing microbes to pathogenicity 70<br/><br/>Classification of infectious diseases 73<br/><br/>Immunity 73<br/><br/>Innate or native immunity 73<br/><br/>Acquired or adaptive immunity 77<br/><br/>Measurement of immune response 80<br/><br/>8. Structure and Functions of the Immune System 82<br/><br/>Central (primary) lymphoid organs 82<br/><br/>Peripheral (secondary) lymphoid organs 84<br/><br/>Cells of the lymphoreticular system 85<br/><br/>Major histocompatibility complex (MHC) 92<br/><br/>9. Antigens 97<br/><br/>Determinants of antigenicity 97<br/><br/>Antigenic specificity 98<br/><br/>Biological classes of antigens 99<br/><br/>Determinants recognised by the<br/><br/>innate immune system 100<br/><br/>10. Antibodies 103<br/><br/>Antibody structure 103<br/><br/>Immunoglobulin classes 106<br/><br/>Abnormal immunoglobulins 109<br/><br/>Immunoglobulin specificities 109<br/><br/>Antibody diversity 110<br/><br/>Class switching 111<br/><br/>Genetic regulation of immunoglobulins 111<br/><br/>Monoclonal antibodies 111<br/><br/>Humanised (chimeric) antibodies 113<br/><br/>Antibody engineering 113<br/><br/>11. Complement System 114<br/><br/>Properties of complement 114<br/><br/>Components of complement 114<br/><br/>Complement activation 115<br/><br/>Complement pathways 115<br/><br/>Regulation of complement activation 117<br/><br/>Biological effects of complement action 118<br/><br/>Quantitation of complement and its components 119<br/><br/>Biosynthesis of complement 120<br/><br/>Deficiencies of the complement system 120<br/><br/>12. Immune Response 122<br/><br/>Humoral immune response (antibody-mediated) 122<br/><br/>Cellular immune response / cell-mediated immunity (CMI) 127<br/><br/>Immunological tolerance 132<br/><br/>Factors affecting immunological tolerance 132<br/><br/>Theories of immune response 133<br/><br/>Idiotypes 134<br/><br/>13. Antigen–Antibody Reactions 136<br/><br/>Stages in antigen–antibody reactions 136<br/><br/>Uses of antigen–antibody<br/><br/>reactions 136<br/><br/>General features of antigen–antibody reactions 137<br/><br/>Reactions on which antigen–antibody<br/><br/>assays are based 137<br/><br/>Precipitation reaction 137<br/><br/>Agglutination reaction 140<br/><br/>Complement fixation test (CFT) 142<br/><br/>Neutralisation tests 143<br/><br/>Radioimmunoassay (RIA) 144<br/><br/>Enzyme immunoassay (EIA) 144<br/><br/>Chemiluminescence immunoassay (CLIA) 147<br/><br/>Immunoelectroblot / western blot techniques 147<br/><br/>Immunochromatographic assay / lateral flow assay 147<br/><br/>Immunoelectron microscopic assays 147<br/><br/>Immunofluorescence assay 147<br/><br/>14. Hypersensitivity 151<br/><br/>Classification of hypersensitivity reaction 151<br/><br/>Type I reactions<br/><br/>(immediate anaphylactic hypersensitivity) 152<br/><br/>Type II reactions: cytolytic and<br/><br/>cytotoxic reactions 155<br/><br/>Type III reactions: immune complex-mediated<br/><br/>hypersensitivity 156<br/><br/>Type IV reactions:<br/><br/>T cell-mediated hypersensitivity (delayed type) 156<br/><br/>15. Immunodeficiency Diseases 160<br/><br/>Primary immunodeficiencies 160<br/><br/>Disorders of specific immunity 160<br/><br/>Disorders of complement 164<br/><br/>Disorders of phagocytosis 164<br/><br/>Secondary immunodeficiencies 165<br/><br/>Laboratory methods to detect<br/><br/>immunodeficiency disorders 165<br/><br/>16. Autoimmunity and Immunohematology 168<br/><br/>Immunological tolerance 168<br/><br/>Mechanisms of autoimmunity 168<br/><br/>Classification of autoimmune diseases 169<br/><br/>Pathogenesis of autoimmune diseases 171<br/><br/>Laboratory tests to detect autoimmune disorders 171<br/><br/>Management of autoimmune disorders 172<br/><br/>Immunohematology 172<br/><br/>17. Immunology of Transplantation and Tumour<br/><br/>Immunity 176<br/><br/>Immunology of transplantation 176<br/><br/>Immunology of malignancy 182<br/><br/>Part III Bacteriology<br/><br/>18. Normal Microbial Flora of the Human Body 186<br/><br/>Role of normal microbial flora 186<br/><br/>Probiotics 188<br/><br/>Normal flora and the immune system 188<br/><br/>Therapeutic use of gut flora 188<br/><br/>19. Antimicrobial Agents 190<br/><br/>Mechanisms of action of antibiotics on<br/><br/>bacterial cells 190<br/><br/>Antimicrobial resistance 191<br/><br/>Antibiotic sensitivity tests 191<br/><br/>Antibiotic policy 194<br/><br/>–– Antibiotic stewardship 194<br/><br/>20. Staphylococci 196<br/><br/>Staphylococcus aureus 196<br/><br/>Other coagulase-positive staphylococci (CoPS) 202<br/><br/>Coagulase-negative staphylococci (CoNS) 202<br/><br/>Micrococci 202<br/><br/>21. Streptococci, Enterococci and Pneumococci 204<br/><br/>Streptococci 204<br/><br/>Streptococcus pyogenes group A streptococci (GAS)] 205<br/><br/>Other hemolytic streptococci 210<br/><br/>Other streptococci 211<br/><br/>Enterococci 212<br/><br/>Pneumococci 212<br/><br/>Streptococcus pneumoniae 212<br/><br/>22. Neisseria and Moraxella 218<br/><br/>Neisseria meningitidis 218<br/><br/>Neisseria gonorrhoeae 221<br/><br/>Non-gonococcal (non-specific) urethritis 223<br/><br/>Commensal neisseriae 223<br/><br/>Moraxella 224<br/><br/>23. Corynebacterium 225<br/><br/>Corynebacterium diphtheriae 225<br/><br/>Other pathogenic corynebacteria 230<br/><br/>Diphtheroids 230<br/><br/>Other coryneform bacteria 231<br/><br/>24. Bacillus 232<br/><br/>Bacillus anthracis 232<br/><br/>Anthracoid bacilli 236<br/><br/>Bacillus cereus 236<br/><br/>Bacillus thuringiensis 237<br/><br/>Bacillus species as sterilisation<br/><br/>indicators (controls) 237<br/><br/>25. Actinomycetes 238<br/><br/>Actinomyces 238<br/><br/>Nocardia 239<br/><br/>Mycetoma (bacterial) 240<br/><br/>–– Actinomycotic mycetoma 240<br/><br/>26. Clostridia 242<br/><br/>Clostridium perfringens 244<br/><br/>Clostridium septicum 246<br/><br/>Clostridium novyi (C. oedematiens) 246<br/><br/>Clostridium histolyticum 246<br/><br/>–– Gas gangrene 246<br/><br/>Clostridium tetani 249<br/><br/>–– Tetanus 250<br/><br/>Clostridium botulinum 252<br/><br/>–– Botulism 253<br/><br/>27. Non-sporing Anaerobic Bacteria 256<br/><br/>Anaerobic cocci 256<br/><br/>Non-sporing anaerobic gram-positive bacilli 256<br/><br/>Anaerobic gram-negative bacilli 257<br/><br/>Anaerobic infections 257<br/><br/>28. Mycobacteria I 260<br/><br/>Mycobacterium tuberculosis 260<br/><br/>Tuberculosis 262<br/><br/>Revised National Tuberculosis<br/><br/>Control Programme (RNTCP) 271<br/><br/>29. Mycobacteria II 273<br/><br/>–– Runyon classification 273<br/><br/>Mycobacterial skin infections 274<br/><br/>Mycobacterium leprae 275<br/><br/>Leprosy 276<br/><br/>30. Enteric Bacilli (Gram-Negative Rods) 281<br/><br/>Escherichia coli 281<br/><br/>Shigella 286<br/><br/>Salmonella 288<br/><br/>–– Enteric fever 290<br/><br/>–– Salmonella gastroenteritis 295<br/><br/>–– Salmonella septicemia 295<br/><br/>Yersinia enterocolitica 296<br/><br/>Edwardsiella tarda 296<br/><br/>Citrobacter diversus and Citrobacter freundii 296<br/><br/>Klebsiella pneumoniae 297<br/><br/>Enterobacter cloacae 298<br/><br/>Hafnia alvei 298<br/><br/>Serratia marcescens 298<br/><br/>Proteus 299<br/><br/>Morganella 299<br/><br/>Providencia 299<br/><br/>Erwinia herbicola 299<br/><br/>31. Vibrionaceae 301<br/><br/>Vibrio cholerae 301<br/><br/>Vibrio mimicus 308<br/><br/>Halophilic vibrios 308<br/><br/>Aeromonas and Plesiomonas 309<br/><br/>32. Gram-Negative Non-fermenters 310<br/><br/>Pseudomonas aeruginosa 310<br/><br/>Stenotrophomonas maltophila 312<br/><br/>Elizabethkingia meningosepticum 312<br/><br/>Alcaligenes and Achromobacter 312<br/><br/>Burkholderia 312<br/><br/>Acinetobacter 314<br/><br/>33. Haemophilus 316<br/><br/>Haemophilus influenzae 316<br/><br/>Haemophilus aegyptius 318<br/><br/>Haemophilus ducreyi 318<br/><br/>Haemophilus parainfluenzae 319<br/><br/>HACEK group of organisms 319<br/><br/>Aggregatibacter 319<br/><br/>Cardiobacterium 319<br/><br/>Kingella 319<br/><br/>Eikenella corrodens 320<br/><br/>34. Brucella and Bordetella 321<br/><br/>Brucella 321<br/><br/>Bordetella 324<br/><br/>Bordetella pertussis 324<br/><br/>Bordetella parapertussis 327<br/><br/>Bordetella bronchiseptica 327<br/><br/>35. Spirochetes 329<br/><br/>Treponema 330<br/><br/>Treponema pallidum 330<br/><br/>–– Syphilis 331<br/><br/>–– Non-venereal treponematoses 337<br/><br/>Non-pathogenic treponemes 338<br/><br/>Borrelia 339<br/><br/>Borrelia recurrentis (replapsing fever) 339<br/><br/>Borrelia vincentii (Vincent’s angina) 340<br/><br/>Borrelia burgdorferi (Lyme disease) 340<br/><br/>Leptospira 341<br/><br/>36. Chlamydia 345<br/><br/>Chlamydia trachomatis 348<br/><br/>–– Trachoma 348<br/><br/>–– Inclusion conjunctivitis 349<br/><br/>–– Infant pneumonia 349<br/><br/>–– Genital infections 349<br/><br/>Chlamydophila pneumoniae 350<br/><br/>Chlamydophila psittaci 350<br/><br/>–– Psittacosis 350<br/><br/>37. Mycoplasma and Ureaplasma 352<br/><br/>Mycoplasma 352<br/><br/>Ureaplasma urealyticum 354<br/><br/>–– Genital infections 354<br/><br/>––Mycoplasma as cell culture contaminants 355<br/><br/>38. Rickettsiae and Related Bacteria<br/><br/>(Arthropod-Borne Bacterial Infections) 356<br/><br/>Rickettsiae 356<br/><br/>Genus Rickettsia 356<br/><br/>–– Typhus fever group 357<br/><br/>–– Spotted fever group 359<br/><br/>Genus Orientia 359<br/><br/>Genus Ehrlichia 360<br/><br/>Genus Coxiella 361<br/><br/>Arthropod-borne bacterial infections 362<br/><br/>Bartonella bacilliformis 362<br/><br/>Bartonella (Rochalimaea) quintana 362<br/><br/>Bartonella henselae 362<br/><br/>39. Miscellaneous Bacteria Causing<br/><br/>Human Infections 364<br/><br/>Yersinia pestis 364<br/><br/>–– Plague 365<br/><br/>–– Yersiniosis 368<br/><br/>Pasteurella multocida 369<br/><br/>Francisella tularensis 369<br/><br/>Alcaligenes faecalis 369<br/><br/>Chromobacterium violaceum 369<br/><br/>Flavobacterium meningosepticum 369<br/><br/>Klebsiella granulomatis 369<br/><br/>Streptobacillus moniliformis and Spirillum minus 370<br/><br/>Campylobacter 371<br/><br/>Helicobacter pylori 372<br/><br/>Legionella pneumophila 373<br/><br/>Capnocytophaga 374<br/><br/>Gardnerella vaginalis 374<br/><br/>Moraxella (Branhamella) catarrhalis 374<br/><br/>Moraxella lacunata 374<br/><br/>Listeria monocytogenes 375<br/><br/>Erysipelothrix rhusiopathiae 375<br/><br/>Part IV Virology<br/><br/>40. Introduction to Virology 377<br/><br/>Morphology 377<br/><br/>Resistance of viruses to physical and<br/><br/>chemical agents 379<br/><br/>Viral replication 380<br/><br/>Viral genetics 382<br/><br/>Classification and nomenclature of<br/><br/>medically important viruses 384<br/><br/>Viroids 386<br/><br/>Prion 386<br/><br/>41. Basic Concepts of Viral Infections 388<br/><br/>Pathogenesis of viral infections 388<br/><br/>Host response to viral infections 390<br/><br/>Laboratory diagnosis of viral diseases 392<br/><br/>Cultivation of viruses 393<br/><br/>Viral assay 396<br/><br/>Assay of infectivity 396<br/><br/>Viral hemagglutination 396<br/><br/>Serological diagnosis 397<br/><br/>Molecular diagnosis 397<br/><br/>42. Bacteriophages 399<br/><br/>Morphology 399<br/><br/>Life cycle 399<br/><br/>Transmission of genetic information 401<br/><br/>Significance of phages in medical microbiology 401<br/><br/>Phage therapy 402<br/><br/>43. Herpesviruses 404<br/><br/>Herpes simplex virus 404<br/><br/>Varicella-zoster virus (VZV) 407<br/><br/>–– Varicella (Chickenpox) 407<br/><br/>Herpes zoster (shingles, zona) 409<br/><br/>Cytomegaloviruses 409<br/><br/>Epstein–Barr virus 411<br/><br/>–– Infectious mononucleosis (glandular fever) 412<br/><br/>Human herpesvirus types 6, 7, 8 413<br/><br/>Herpesvirus simiae: B virus 414<br/><br/>44. Pox and Other Viruses 416<br/><br/>Poxvirus 416<br/><br/>–– Variola and vaccinia 416<br/><br/>–– Smallpox 417<br/><br/>–– Other poxvirus diseases 418<br/><br/>Papillomavirus 418<br/><br/>Polyomavirus 419<br/><br/>Parvovirus 419<br/><br/>45. Adenovirus 421<br/><br/>Adenoviruses 421<br/><br/>Adeno-associated viruses (AAV) 423<br/><br/>46. Picornavirus 424<br/><br/>Enteroviruses 424<br/><br/>Poliovirus 425<br/><br/>Coxsackieviruses 430<br/><br/>Echoviruses 432<br/><br/>New enterovirus types 432<br/><br/>Rhinoviruses 433<br/><br/>47. Reoviridae 435<br/><br/>Reovirus 435<br/><br/>Orbivirus 435<br/><br/>Rotavirus 435<br/><br/>Other diarrheagenic viruses 436<br/><br/>–– Calicivirus 436<br/><br/>–– Adenovirus 436<br/><br/>–– Astrovirus 437<br/><br/>–– Coronavirus 437<br/><br/>48. Orthomyxovirus 438<br/><br/>Influenza virus 438<br/><br/>49. Paramyxovirus, Pneumovirus and Rubella 446<br/><br/>Antigenic structure of paramyxoviruses 446<br/><br/>Classification of paramyxoviruses 447<br/><br/>Parainfluenza virus 447<br/><br/>Mumps virus 447<br/><br/>Newcastle disease virus (NDV) 449<br/><br/>Pneumovirus 449<br/><br/>Respiratory syncytial virus (RSV) 449<br/><br/>Morbillivirus 450<br/><br/>Measles (Rubeola) virus 450<br/><br/>Nipah and Hendra viruses 453<br/><br/>Human metapneumovirus 454<br/><br/>Rubella virus 454<br/><br/>50. Arthropod- and Rodent-Borne Viral Infections 457<br/><br/>Arthropod-borne viruses 457<br/><br/>Togaviridae 460<br/><br/>–– Alphavirus 460<br/><br/>Flaviviridae 461<br/><br/>Filoviridae 465<br/><br/>Bunyaviridae 467<br/><br/>Reoviridae 467<br/><br/>Ungrouped arboviruses 468<br/><br/>Rodent-borne viruses 468<br/><br/>51. Rhabdovirus and Other Viral and<br/><br/>Prion Diseases 470<br/><br/>Rabies 470<br/><br/>Slow virus diseases 477<br/><br/>52. Hepatitis Viruses 480<br/><br/>Types of viral hepatitis 480<br/><br/>Hepatitis A virus (HAV) 480<br/><br/>Hepatitis B virus (HBV) 482<br/><br/>Hepatitis C virus (HCV) 489<br/><br/>Hepatitis D (delta) virus (HDV) 490<br/><br/>Hepatitis E virus (HEV) 490<br/><br/>Hepatitis G virus (HGV) 491<br/><br/>53. Retrovirus 493<br/><br/>Human immunodeficiency virus (HIV) 493<br/><br/>Acquired immune deficiency syndrome (AIDS) 498<br/><br/>54. Oncogenic Viruses and<br/><br/>Other Miscellaneous Viruses 510<br/><br/>Oncogenic viruses 510<br/><br/>Oncogenic DNA viruses 511<br/><br/>Oncogenic RNA viruses 512<br/><br/>Oncogenes 514<br/><br/>Miscellaneous viruses 515<br/><br/>–– Human papillomaviruses 515<br/><br/>–– Human polyomaviruses 515<br/><br/>–– Parvoviruses 515<br/><br/>Viral hemorrhagic fevers 516<br/><br/>–– Arenaviruses 516<br/><br/>–– Filoviruses 516<br/><br/>Coronaviruses 517<br/><br/>–– Severe acute respiratory syndrome (CoV-SARS) 518<br/><br/>––MERS-CoV 518<br/><br/>–– COVID-19 519<br/><br/>55. Antiviral Chemotherapy and<br/><br/>Immunoprophylaxis 521<br/><br/>Inhibitors of nucleic acid synthesis 522<br/><br/>Protease inhibitors 522<br/><br/>Other types of antiviral agents 522<br/><br/>Interferons 523<br/><br/>Resistance to antiviral agents 523<br/><br/>Immunoprophylaxis of viral diseases 523<br/><br/>Part V Medical Mycology<br/><br/>56. Basic Mycology and Superficial Mycoses 526<br/><br/>Characteristics of fungi 526<br/><br/>Classification of fungi 526<br/><br/>Superficial mycoses 529<br/><br/>–– Cutaneous mycoses 529<br/><br/>–– Subcutaneous mycoses 534<br/><br/>57. Systemic Fungal Infections 541<br/><br/>Systemic mycoses (dimorphic fungi) 541<br/><br/>Histoplasmosis 541<br/><br/>Blastomycosis 542<br/><br/>Paracoccidioidomycosis 543<br/><br/>Coccidioidomycosis 543<br/><br/>Treatment of systemic mycoses 544<br/><br/>Opportunistic mycoses 545<br/><br/>Aspergillosis 545<br/><br/>Penicillosis 547<br/><br/>Zygomycosis (mucormycosis, phycomycosis) 547<br/><br/>Candidosis (candidiasis/moniliasis) 548<br/><br/>Cryptococcosis (torulosis) 550<br/><br/>Pneumocystis jirovecii 551<br/><br/>Specific fungal infections 552<br/><br/>Otomycosis 552<br/><br/>Oculomycosis (keratomycosis,<br/><br/>fungal keratitis, mycotic keratitis) 552<br/><br/>Mycotic poisoning 553<br/><br/>58. Laboratory Diagnosis of Fungal Infections 556<br/><br/>Specimen 556<br/><br/>Laboratory methods of isolation and identification 556<br/><br/>Treatment 559<br/><br/>Part VI Clinical Microbiology as Applied to Infectious<br/><br/>Diseases<br/><br/>59. Diagnostic Microbiology 560<br/><br/>Specimen collection and transport (pre-test) 561<br/><br/>Processing of samples in the laboratory<br/><br/>(test procedure) 561<br/><br/>Reporting of results (post-test) 562<br/><br/>Quality control in a clinical microbiology laboratory 563<br/><br/>60. Systemic Infections and<br/><br/>Their Laboratory Diagnosis 565<br/><br/>CVS and bloodstream infections 565<br/><br/>Fever of unknown origin 569<br/><br/>Gastrointestinal and hepatobiliary tract infections 572<br/><br/>Skin, soft tissue and musculoskeletal infections 575<br/><br/>Central nervous system infections 578<br/><br/>Respiratory tract infections 582<br/><br/>Genitourinary and sexually transmitted infections 585<br/><br/>Vector-borne and zoonotic diseases 591<br/><br/>Miscellaneous infections 592<br/><br/>Congenital infections 594<br/><br/>61. Emerging and Re-emerging Infections 596<br/><br/>Disease transmission from animals to humans 596<br/><br/>Public health emergency infections 596<br/><br/>–– Zika virus disease 597<br/><br/>Indian scenario of various infections 597<br/><br/>Drug resistance 598<br/><br/>Bioterrorism 598<br/><br/>Communicable disease programmes<br/><br/>under the national health mission 598<br/><br/>62. Health Care-Associated Infections 601<br/><br/>Common types of health care-associated infections 602<br/><br/>Sources and reservoirs of health<br/><br/>care-associated infections 604<br/><br/>Measures to control Infection in the<br/><br/>health care setting 605<br/><br/>Investigation and follow-up of outbreaks of disease 608<br/><br/>Monitoring and regulation of HCAI:<br/><br/>Hospital Infection Control Committee (HICC) 609<br/><br/>63. Immunoprophylaxis 610<br/><br/>Active immunisation 610<br/><br/>Passive immunisation 612<br/><br/>Combined active and passive immunisation 612<br/><br/>Individual immunisation 612<br/><br/>Vaccination during outbreaks 613<br/><br/>Newer vaccines in the experimental or<br/><br/>clinical trial stages 613<br/><br/>Immunomodulation 613<br/><br/>64. Bacteriology of Water, Air, Milk and Food 615<br/><br/>65. Biomedical Waste Management 623<br/><br/>Types of biomedical waste 623<br/><br/>General principles of waste management 624<br/><br/>Steps in waste management 624<br/><br/>Methods of waste management 624<br/><br/>Spill management 624<br/><br/>BMW rules 2016, amended in 2018 625<br/><br/>66. Quality Control and Recent Advances<br/><br/>in Diagnostic Microbiology 627<br/><br/>Automated and semi-automated systems<br/><br/>for culture 627<br/><br/>Molecular methods 627<br/><br/>Quality control and accreditation of laboratories 629<br/><br/>Further Reading 631<br/><br/>Index 634 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
First published in 1978, Ananthanarayan and Paniker’s Textbook of Microbiology has been a trusted textbook on microbiology for more than four decades and has evolved with the rapidly changing field of medical microbiology. To stay abreast of recent developments across the global and local infectious disease spectra, the new Competency-Based Medical Education (CBME) curriculum is aimed at integrating microbiology into the system-based approach to human disease. The eleventh edition of Ananthanarayan and Paniker's Textbook of Microbiology has been revised to address this restructuring of the curriculum and to make it better suited for the shorter course duration and system-based integration. Chapters have been pruned without compromising on essential elements which have been presented in a lucid style and flow for an easy and enjoyable reading experience. Several clinical and laboratory images have been updated and line diagrams included for better visual impact and comprehension. Recent advances in disease detection, molecular diagnosis, quality control, infection prevention and control, public health and epidemiology and preventive strategies including national programmes have been brought up to date. An entire chapter (chapter 60) has been devoted to the essence of the competency-based integrated approach to system-wise infectious diseases. This chapter delves into the entire gamut of organisms involved in infectious diseases commonly affecting various systems of the human body and will pave the way for the study of pathogenic microorganisms as individuals and as groups. The traditional approach to the learning and understanding of the microbe–host–environment interaction, pathogenesis, clinical presentations, diagnosis, treatment and prevention of infections has been retained. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Department Name |
Microbiology |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Reference Books |
